Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Silverback Therapeutics patents TGFBR1 inhibitors

May 6, 2021

Vivace advances phase I trial of VT-3989 in solid tumors

May 6, 2021

Preclinical characterization of novel small molecule inhibitor of CD38, RBN-013209

May 5, 2021

FDA clears IND for phase I/II study of Clarity's prostate cancer theranostic products

May 5, 2021

Positive topline data from GENESIS phase III study of motixafortide plus G-CSF in multiple myeloma

May 5, 2021

Cellectar Biosciences describes new phospholipid-drug conjugates for cancer

May 5, 2021

Incyte discloses new CDK2/cyclin E inhibitors

May 5, 2021

Zenshine compounds targeting E-NPP 1 have antitumor activity

May 5, 2021

Aprea begins enrollment in first-in-human study of APR-548 for TP53-mutated MDS

May 5, 2021

PXS-5505 to enter preclinical evaluation for glioblastoma

May 4, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026